Haisco's Ciprofol Receives U.S. FDA Approval with CDMO Support from Jiuzhou Pharma
Jiuzhou Pharma Assists Client with U.S. FDA Approval of IV Anesthesia Zhejiang JiuZhou Pharmaceutical Co Ltd (SSE:603456.SH) TAIZHOU CITY, ZHEJIANG, CHINA, July 22, 2026 /EINPresswire.com/ -- On June 1, Haisco Pharmaceutical Group announced …